NCT02004028 2024-02-20Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma ParticipantsVerastem, Inc.Phase 2 Terminated35 enrolled 15 charts
NCT00486512 2020-09-03Chemoprevention of Colorectal AdenomasColotech A/SPhase 3 Terminated350 enrolled
NCT02926209 2019-07-16Post Market Evaluation of Aer-O-Scope VisualizationGI View Ltd.Phase NA Terminated104 enrolled 5 charts